Effects of calcium antagonists on beta-receptors of cultured cardiac myocytes isolated from neonatal rat ventricle.
The effects of calcium antagonists (verapamil, diltiazem, and nicardipine) on beta-adrenergic receptors of cultured cardiac myocytes isolated from neonatal rat ventricle were studied with the hydrophilic ligand [3H]CGP-12177, which identifies cell surface-bound beta-receptors. The three calcium antagonists suppressed spontaneous beating of the myocytes, increased the number of beta-receptors, but did not alter the affinity (Kd). These effects were dose and time dependent. Verapamil (10(-6) M) increased the beta-receptor density by about 13% after 6 hours of incubation, and this increase in density reached a plateau of about 45% after 24 hours of incubation. beta-Receptor density increased by 15% with 5 x 10(-7) M and by 37% with 10(-6) M verapamil. The increased beta-receptors appeared to retain their normal function, as assessed by the increased spontaneous beating of the myocytes in response to applied isoproterenol. The increase in beta-receptors was abolished by colchicine but not by cycloheximide. When the calcium ion concentration of the medium was lowered to 0.1 mM, no significant change occurred in the density of beta-receptors compared with that in 1.8-mM Ca2+ medium. The results suggest that calcium antagonists increase beta-receptors by accelerating recycling by microtubules but not by decreasing the inward calcium current. Such effects of calcium antagonists may be clinically important and promise insight into the mechanism of the withdrawal phenomenon of calcium antagonists.
Yonemochi
H
H
Department of Internal Medicine, Medical College of Oita, Japan.
Saikawa
T
T
Takakura
T
T
Ito
S
S
Takaki
R
R
D000818:Animals; D000831:Animals, Newborn; D001696:Biomechanical Phenomena; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002469:Cell Separation; D002478:Cells, Cultured; D006352:Heart Ventricles; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D011943:Receptors, Adrenergic, beta; D014700:Verapamil